CATALYST PHARMACEUTICALS, INC. (CPRX) scores 88 out of 100 on boothcheck's 11-model valuation framework. Verdict: Excellent The estimated fair value is 32.68, representing a 32% margin of safety. Quantitative score: 86/100. Qualitative score: 80/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.